发明名称 ANTI-AXL ANTIBODIES AND USES THEREOF
摘要 The present invention relates to anti-Axl antibodies and uses thereof in diagnostic and therapeutic methods. More particularly, the present invention relates to a monoclonal antibody having specificity for Axl comprising an heavy chain variable region comprising SEQ ID NO:2 in the H-CDR1 region, SEQ ID NO:3 in the H-CDR2 region and SEQ ID NO:4 in the H-CDR3 region; and a light chain variable region comprising SEQ ID NO: 6 in the L-CDR1 region, SEQ ID NO:7 in the L-CDR2 region and SEQ ID NO:8 in the L-CDR3 region. Said monoclonal antibody binds to the extracellular domain of Axl via, SEQ ID NO:9 and SEQ ID NO: 10.
申请公布号 US2014227283(A1) 申请公布日期 2014.08.14
申请号 US201214127416 申请日期 2012.06.22
申请人 Robert Bruno;Fauvel Benedicte;Cheve Gwenael;Yasri Aziz;Larbouret Christel;Leconet Wilhem;Chardes Thierry;Larroque Christian;Pelegrin Andre 发明人 Robert Bruno;Fauvel Benedicte;Cheve Gwenael;Yasri Aziz;Larbouret Christel;Leconet Wilhem;Chardes Thierry;Larroque Christian;Pelegrin Andre
分类号 C07K16/28;G01N33/68;G01N33/574 主分类号 C07K16/28
代理机构 代理人
主权项 1. A monoclonal antibody or an antigen binding fragment thereof, wherein said monoclonal antibody or antigen binding fragment thereof has specificity for Axl and comprises an heavy chain variable region comprising SEQ ID NO:2 in the H-CDR1 region, SEQ ID NO:3 in the H-CDR2 region and SEQ ID NO:4 in the H-CDR3 region; and a light chain variable region comprising SEQ ID NO:6 in the L-CDR1 region, SEQ ID NO:7 in the L-CDR2 region and SEQ ID NO:8 in the L-CDR3 region.
地址 Montpellier Cedex 5 FR
您可能感兴趣的专利